Physicians in the era of genomic medicine will have the opportunityto move from intense, crisis-driven intervention to predictivemedicine. Over the next decade or two, it seems likely thatwe will screen entire populations or specific subgroups forgenetic information in order to target interventions to individualpatients that will improve their health and prevent disease.Until now, population screening involving genetics has focusedon the identification of persons with certain mendelian disordersbefore the appearance of symptoms and thus on the preventionof illness1 (e.g., screening of newborns for phenylketonuria),the testing of selected populations for carrier status, . . . [Full Text of this Article]
Principles of Population Screening
Newborn Screening
Carrier Screening of Adult Populations for Single-Gene Disorders
TaySachs Disease
Cystic Fibrosis
Population Screening for Genetic Susceptibility to Common Diseases
Hereditary Hemochromatosis
Factor V Leiden
Ethical, Legal, and Social Issues
Testing Children for Adult-Onset Disorders
Unanticipated Information
Misattribution of Paternity
Unexpected Associations among Diseases
Oversight and Policy Issues
Source Information
From the Office of Genomics and Disease Prevention, Centers for Disease Control and Prevention, Atlanta (M.J.K.); and the Departments of Human Genetics and Pediatrics, the David Geffen School of Medicine at UCLA, and the UCLA Center for Society, the Individual and Genetics, Los Angeles (L.L.M., E.R.B.M.).
Address reprint requests to Dr. Edward McCabe at the Department of Pediatrics, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave., Los Angeles, CA 90095-1752, or at emccabe@mednet.ucla.edu.
Related Letters:
Population Screening
Stabler S. P., Mudd S. H., Fielding R., Lam W., Leung G. M., Khoury M. J., McCabe L. L., McCabe E. R.B.
Extract |
Full Text |
PDF
N Engl J Med 2003;
348:1604-1605, Apr 17, 2003.
Correspondence
This article has been cited by other articles:
Manamperi, A.
(2008). Current Developments in Genomics and Personalized Health Care: Impact on Public Health. Asia Pac J Public Health
20: 242-250
[Abstract]
Cappelen, A W, Norheim, O F, Tungodden, B
(2008). Genomics and equal opportunity ethics. J. Med. Ethics
34: 361-364
[Abstract][Full Text]
Scirica, C. V., Celedon, J. C.
(2007). Genetics of Asthma: Potential Implications for Reducing Asthma Disparities. Chest
132: 770S-781S
[Abstract][Full Text]
Hutchison, C. A. III
(2007). DNA sequencing: bench to bedside and beyond. Nucleic Acids Res
35: 6227-6237
[Abstract][Full Text]
Kerruish, N. J., Campbell-Stokes, P. L., Gray, A., Merriman, T. R., Robertson, S. P., Taylor, B. J.
(2007). Maternal Psychological Reaction to Newborn Genetic Screening for Type 1 Diabetes. Pediatrics
120: e324-e335
[Abstract][Full Text]
Hall, W. D
(2007). A research agenda for assessing the potential contribution of genomic medicine to tobacco control. Tobacco Control
16: 53-58
[Abstract][Full Text]
Seo, D., Ginsburg, G. S., Goldschmidt-Clermont, P. J.
(2006). Gene Expression Analysis of Cardiovascular Diseases: Novel Insights Into Biology and Clinical Applications. J Am Coll Cardiol
48: 227-235
[Abstract][Full Text]
Ioannidis, J. P A
(2006). Commentary: Grading the credibility of molecular evidence for complex diseases. Int J Epidemiol
35: 572-578
[Full Text]
Hoff, T., Hoyt, A.
(2006). Practices and perceptions of long-term follow-up among state newborn screening programs.. Pediatrics
117: 1922-1929
[Abstract][Full Text]
Fulda, K G, Lykens, K
(2006). Ethical issues in predictive genetic testing: a public health perspective.. J. Med. Ethics
32: 143-147
[Abstract][Full Text]
Bailey, D. B. Jr, Skinner, D., Warren, S. F.
(2005). Newborn Screening for Developmental Disabilities: Reframing Presumptive Benefit. Am. J. Public Health
95: 1889-1893
[Abstract][Full Text]
Huber, A., Bentz, E.-K., Schneeberger, C., Huber, J. C., Hefler, L., Tempfer, C.
(2005). Ten Polymorphisms of Estrogen-Metabolizing Genes and a Family History of Colon Cancer--An Association Study of Multiple Gene-Gene Interactions. Reproductive Sciences
12: e51-e54
[Abstract]
Martino, S., Marconi, P., Tancini, B., Dolcetta, D., De Angelis, M.G. C., Montanucci, P., Bregola, G., Sandhoff, K., Bordignon, C., Emiliani, C., Manservigi, R., Orlacchio, A.
(2005). A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease. Hum Mol Genet
14: 2113-2123
[Abstract][Full Text]
Crow, J. F., Johnson, T. E.
(2005). Comments. J. Gerontol. B Psychol. Sci. Soc. Sci.
60: 7-11
[Full Text]
Ryff, C. D., Singer, B. H.
(2005). Social Environments and the Genetics of Aging: Advancing Knowledge of Protective Health Mechanisms. J. Gerontol. B Psychol. Sci. Soc. Sci.
60: 12-23
[Abstract][Full Text]
Abel, E., Horner, S. D., Tyler, D., Innerarity, S. A.
(2005). The Impact of Genetic Information on Policy and Clinical Practice. Policy Politics Nursing Practice
6: 5-14
[Abstract]
Khoury, M. J, Millikan, R., Little, J., Gwinn, M.
(2004). The emergence of epidemiology in the genomics age. Int J Epidemiol
33: 936-944
[Full Text]
Palmer, L. J
(2004). The New Epidemiology: putting the pieces together in complex disease aetiology. Int J Epidemiol
33: 925-928
[Full Text]
Newman, J. H., Trembath, R. C., Morse, J. A., Grunig, E., Loyd, J. E., Adnot, S., Coccolo, F., Ventura, C., Phillips, J. A. III, Knowles, J. A., Janssen, B., Eickelberg, O., Eddahibi, S., Herve, P., Nichols, W. C., Elliott, G.
(2004). Genetic basis of pulmonary arterial hypertension: Current understanding and future directions. J Am Coll Cardiol
43: 33S-39S
[Abstract][Full Text]
Barker, J. M., Goehrig, S. H., Barriga, K., Hoffman, M., Slover, R., Eisenbarth, G. S., Norris, J. M., Klingensmith, G. J., Rewers, M.
(2004). Clinical Characteristics of Children Diagnosed With Type 1 Diabetes Through Intensive Screening and Follow-Up. Diabetes Care
27: 1399-1404
[Abstract][Full Text]
Tempfer, C. B., Jirecek, S., Riener, E. K., Zeisler, H., Denschlag, D., Hefler, L., Husslein, P. W.
(2004). Polymorphisms of Thrombophilic and Vasoactive Genes and Severe Preeclampsia: A Pilot Study. Reproductive Sciences
11: 227-231
[Abstract]
Chace, D. H., Kalas, T. A., Naylor, E. W.
(2003). Use of Tandem Mass Spectrometry for Multianalyte Screening of Dried Blood Specimens from Newborns. Clin. Chem.
49: 1797-1817
[Abstract][Full Text]
Guttmacher, A. E., Collins, F. S.
(2003). Welcome to the Genomic Era. NEJM
349: 996-998
[Full Text]
Clayton, E. W.
(2003). Ethical, Legal, and Social Implications of Genomic Medicine. NEJM
349: 562-569
[Full Text]
Marian, A.J., Roberts, R.
(2003). To Screen or Not Is Not the Question-- It Is When and How to Screen. Circulation
107: 2171-2174
[Full Text]
Stabler, S. P., Mudd, S. H., Fielding, R., Lam, W., Leung, G. M., Khoury, M. J., McCabe, L. L., McCabe, E. R.B.
(2003). Population Screening. NEJM
348: 1604-1605
[Full Text]
Merikangas, K. R., Risch, N.
(2003). Will the Genomics Revolution Revolutionize Psychiatry?. Am. J. Psychiatry
160: 625-635
[Full Text]
Cooper, R. S., Psaty, B. M.
(2003). Genomics and Medicine: Distraction, Incremental Progress, or the Dawn of a New Age?. ANN INTERN MED
138: 576-580
[Abstract][Full Text]
Cui, H., Cruz-Correa, M., Giardiello, F. M., Hutcheon, D. F., Kafonek, D. R., Brandenburg, S., Wu, Y., He, X., Powe, N. R., Feinberg, A. P.
(2003). Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk. Science
299: 1753-1755
[Abstract][Full Text]
Beutler, E., Hoffbrand, A. V., Cook, J. D.
(2003). Iron Deficiency and Overload. ASH Education Book
2003: 40-61
[Abstract][Full Text]